JPRN-UMIN000031837已完成未知
Early combination efficacy of vildagliptin (DPP-4 inhibitor) in basal-bolus insulin therapy with metformin: randomised crossover study - Early combination efficacy of vildagliptin (DPP-4 inhibitor) in basal-bolus insulin therapy with metformin
General Inuyama Chuo Hospital0 个研究点目标入组 30 人开始时间: 2018年3月22日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •renal dysfunction (patients whose estimated glomerular filtration rate was less than 45 ml/min/1.73m2) judged to be unsuitable for participation for medical reasons
研究者
相似试验
已完成
不适用
To compare the effect of pioglitazone vs vildagliptin in type 2 diabetes mellitus patients not responding to combination of metformin and sulfonylureas.CTRI/2013/04/003582investigator initiated trial50
未知
3 期
Efficacy and safety of vildagliptin as add-on therapy to metformin in patients with type 2 diabetesType 2 diabetes mellitusJPRN-jRCT2080221679ovartis Pharma K.K.136
已完成
不适用
Comparison of DPP-4 inhibitors, vildagliptin and linagliptin in type2 diabetesType 2 diabetes mellitusJPRN-UMIN000010445Yokohama City University Medical Center100
进行中（未招募）
1 期
correlation between gastric motility and appetitehealthy volunteersno medical condition, drug will be studied because they are known to influence gastric motilityEUCTR2013-004978-95-BEKULeuven14
已完成
不适用
The effects of vildagliptin as a DPPIV inhibitor on vascular endothelial and myocardial injury in patients with type II diabetes mellitus.Type II diabetes mellitusJPRN-UMIN000007111ippon Medical School Department of Medicine Division of Cardiology, Hepatology,Geriatrics and Integrated Medicine40